Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
暂无分享,去创建一个
H. Kantarjian | A. Deisseroth | B. Andersson | K. van Besien | P. McCarthy | R. Champlin | A. Deisseroth | I. Khouri | D. Przepiorka | W. Pugh | B. Andersson | K. Besien | S. Giralt | R. Mehra | I. Khouri | J. Gajewski | Y. Moon | P. Williams | F. Cabanillas | F. Cabanillas | S. Giralt | J. Gajewski | Patrick Williams
[1] B. Andersson,et al. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] K. van Besien,et al. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. , 1995, Bone marrow transplantation.
[3] A. Deisseroth,et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts , 1995 .
[4] K. van Besien,et al. High-dose melphalan allows durable engraftment of allogeneic bone marrow. , 1995, Bone marrow transplantation.
[5] J. Gribben,et al. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. , 1994, Blood.
[6] K. van Besien,et al. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[8] A. Goldstone,et al. High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] S. Tucker,et al. ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Dimopoulos,et al. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation , 1994, American journal of hematology.
[11] A. Norton,et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Deisseroth,et al. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation. , 1994, Bone marrow transplantation.
[13] E. Abella,et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. , 1994, Blood.
[14] M. A. Tanner,et al. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Armitage,et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] A. Freedman. Expression and function of adhesion receptors on normal B cells and B cell non-Hodgkin's lymphomas. , 1993, Seminars in hematology.
[17] A. Freedman,et al. Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] M. Strawderman,et al. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] T M Grogan,et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[20] J. Armitage,et al. Treatment of non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[21] G. Pinkus,et al. Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] W. Velasquez,et al. CHOP-Bleo plus interferon for stage IV low-grade lymphoma. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] D. Longo,et al. What's the deal with follicular lymphomas? , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] G. Schoch,et al. Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant , 1993, Annals of Internal Medicine.
[25] M. Oken,et al. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. , 1992, The New England journal of medicine.
[26] L. Gordon,et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. , 1992, The New England journal of medicine.
[27] R. Chopra,et al. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] R. Levy,et al. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. , 1992, The New England journal of medicine.
[29] J. L. Goodman,et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.
[30] J. Bosq,et al. Burkitt's lymphoma in adults: a retrospective study of 46 cases. , 1992, Nouvelle revue francaise d'hematologie.
[31] C. Lawton,et al. Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] D. Neuberg,et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. , 1991, Blood.
[33] S. Piantadosi,et al. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. , 1991, Blood.
[34] K. Sullivan,et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. , 1990, The New England journal of medicine.
[35] A. Rimm,et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. , 1990, Blood.
[36] X. Troussard,et al. Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] P. Colombat,et al. The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] K. Sullivan,et al. Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] H. Lazarus,et al. The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation , 1990 .
[40] E. Copelan,et al. Allogeneic marrow transplantation in non-Hodgkin's lymphoma. , 1990, Bone marrow transplantation.
[41] K. Sullivan,et al. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. , 1989, Bone marrow transplantation.
[42] Hu Yf,et al. Fetal islet cell transplantation in China. , 1989 .
[43] D. Weisenburger,et al. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. , 1989, Bone marrow transplantation.
[44] N. Schmitz,et al. Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. , 1988, Blood.
[45] H. Deeg,et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] K. Anderson,et al. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.
[47] J. Armitage,et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.
[48] L. R. Hill,et al. A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone. , 1987, Transplantation proceedings.
[49] S. Jagannath,et al. High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies. , 1986, European journal of cancer & clinical oncology.
[50] P. Ljungman,et al. Marrow transplantation for non-Hodgkin's lymphoma: a multi-centre study from the European Co-operative Bone Marrow Transplant Group. , 1986, Bone marrow transplantation.
[51] J. Fay,et al. High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] A. Goldstone,et al. Clinical studies of ABMT in non-Hodgkin's lymphoma. , 1986, Clinics in haematology.
[53] H. Deeg,et al. Treatment of non‐Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation , 2007, Hematological oncology.
[54] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[55] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .